newsfilter
← Latest News
GlobeNewswire·

Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104

PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (NASDAQ:GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable